AQUESTIVE THERAPEUTICS INC's ticker is AQST and the CUSIP is 03843E104. A total of 66 filers reported holding AQUESTIVE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 16.03 and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,728 | -14.9% | 1,129,189 | -8.2% | 0.00% | 0.0% |
| Q2 2023 | $2,030 | +243.5% | 1,230,196 | +137.1% | 0.00% | +200.0% |
| Q1 2023 | $591 | +41.7% | 518,800 | +12.1% | 0.00% | 0.0% |
| Q4 2022 | $417 | -100.0% | 462,737 | -48.6% | 0.00% | 0.0% |
| Q3 2022 | $1,054,000 | +34.3% | 900,800 | -26.5% | 0.00% | 0.0% |
| Q2 2022 | $785,000 | +772.2% | 1,226,400 | +3475.5% | 0.00% | – |
| Q1 2022 | $90,000 | +104.5% | 34,300 | +204.7% | 0.00% | – |
| Q4 2021 | $44,000 | -94.7% | 11,257 | -94.1% | 0.00% | -100.0% |
| Q3 2021 | $827,000 | -15.1% | 189,669 | -22.7% | 0.00% | 0.0% |
| Q2 2021 | $974,000 | -33.0% | 245,448 | -9.7% | 0.00% | -50.0% |
| Q4 2020 | $1,454,000 | +125.8% | 271,800 | -7.6% | 0.00% | +100.0% |
| Q1 2020 | $644,000 | +40.0% | 294,051 | +272.2% | 0.00% | – |
| Q4 2019 | $460,000 | – | 79,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bratton Capital Management, L.P. | 9,810,958 | $16,188,081 | 100.00% |
| Vahanian & Associates Financial Planning Inc. | 725,208 | $1,196,593 | 3.78% |
| Bracebridge Capital, LLC | 428,571 | $707,142 | 0.39% |
| Latash Investments, LLC | 243,134 | $401,171 | 0.32% |
| XTX Topco Ltd | 138,145 | $227,939 | 0.04% |
| ARMISTICE CAPITAL, LLC | 1,158,000 | $1,910,700 | 0.03% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 84,355 | $139,186 | 0.01% |
| Hillsdale Investment Management Inc. | 66,600 | $109,890 | 0.01% |
| D.B. Root & Company, LLC | 12,950 | $21,368 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 147,856 | $243,962 | 0.01% |